The study demonstrated that CBP significantly mitigated cataract development by decreasing malondialdehyde (MDA) levels and enhancing the activities of antioxidant enzymes glutathione peroxidase (GSH-Px) and superoxide dismutase (SOD) within the lens
View Study [2]"Safety, tolerability, pharmacokinetics, and pharmacodynamics of cagrilintide with semaglutide" Enebo LB et al., 2021 Finding: Phase 1b trial demonstrated that combining cagrilintide with semaglutide 2.4mg resulted in up to 17.1% weight loss at 20 weeks, with the combination being well-tolerated
Thus, further exploration is warranted of the combination of Semaglutide and VLCD warrants as a novel approach to T2D management," the researchers concluded
Given the fill weight variance noted in Finnrick testing (the 10mg vial COA showed 12.74mg measured), your actual concentration may be higher than calculated if you are working from the labeled weight
Long-acting injectable formulations have been developed for several peptide drugs, reducing dosing frequency and potentially improving patient adherence